1. AB0152 Microarrays gene expression profiling of monocytes from systemic lupus erythematosus patients: novel genes and pathways involved in the disease. (12th June 2018) Authors: Perez-Sanchez, C.; Cecchi, I.; Aguirre, M.A.; Pérez-Sánchez, L.; Luque-Tevar, M.; Barbarroja, N.; Ruiz-Limón, P.; Jiménez-Gómez, Y.; Arias de la Rosa, I.; Abalos-Aguilera, M.D.C.; Segui, P.; Collantes, E.; Cuadrado, M.J.; López-Pedrera, C. Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 2 Page Start: 1266 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. AB0409 APL PREVALENCE IN WOMEN WITH LATE PREGNANCY COMPLICATION AND LOW-RISK FOR CHROMOSOMAL ABNORMALITIES. (2nd June 2020) Authors: Foddai, S. G.; Radin, M.; Cecchi, I.; Rubini, E.; Gaito, S.; Marozio, L.; Manetta, T.; Mengozzi, G.; Sciascia, S.; Roccatello, D. Journal: Annals of the rheumatic diseases Issue: Volume 79(2020)Supplement 1 Page Start: 1504 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. AB0566 Anti-phospholipid antibodies sero-negativization in systemic lupus erythematosus patients treated with belimumab. (12th June 2018) Authors: Rubini, E.; Radin, M.; Cecchi, I.; Roccatello, D.; Sciascia, S. Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 2 Page Start: 1437 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. AB0657 Cyclophosphamide-sparing role of an intensified b-cell depletion protocol in anca-associated vasculitis: a case-control study. (12th June 2018) Authors: Roccatello, D.; Fenoglio, R.; Rossi, D.; Radin, M.; Cecchi, I.; Murgia, S.; Baldovino, S.; Rubini, E.; Sciascia, S. Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 2 Page Start: 1473 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. AB0666 Clinical and serological outcomes of patients with giant cell arteritis treated with tocilizumab or abatacept as steroid-sparing agents. (12th June 2018) Authors: Rossi, D.; Cecchi, I.; Rubini, E.; Radin, M.; Sciascia, S.; Roccatello, D. Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 2 Page Start: 1477 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Defective glucose and lipid metabolism in rheumatoid arthritis is determined by chronic inflammation in metabolic tissues. (12th March 2018) Authors: Arias de la Rosa, I.; Escudero‐Contreras, A.; Rodríguez‐Cuenca, S.; Ruiz‐Ponce, M.; Jiménez‐Gómez, Y.; Ruiz‐Limón, P.; Pérez‐Sánchez, C.; Ábalos‐Aguilera, M. C.; Cecchi, I.; Ortega, R.; Calvo, J.; Guzmán‐Ruiz, R.; Malagón, M. M.; Collantes‐Estevez, E.; Vidal‐Puig, A.; López‐Pedrera, Ch.; Barbarro... Journal: Journal of internal medicine Issue: Volume 284:Number 1(2018) Page Start: 61 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. FRI0327 Reliability of la and diagnostic performance of aps/pt in different clinical settings of aps: a multicenter study. (12th June 2018) Authors: Radin, M.; Cecchi, I.; Rubini, E.; Scotta, A.M.; Rolla, R.; Montaruli, B.; Pergolini, P.; Mengozzi, G.; Muccini, E.; Roccatello, D.; Sciascia, S. Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 2 Page Start: 700 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. FRI0333 B-cells depletion as rescue therapy for extra-criteria manifestations of primary antiphospholipid syndrome. (12th June 2018) Authors: Sciascia, S.; Radin, M.; Cecchi, I.; Rubini, E.; Rossi, D.; Bazzan, M.; Roccatello, D. Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 2 Page Start: 703 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. FRI0589 CLINICAL ACCURACY OF ANTI-PHOSPHATIDYLSERINE/PROTHROMBIN AND ANTI-BETA2GLYCOPROTEIN I DOMAIN I FOR PREDICTING CLINICAL MANIFESTATIONS OF ANTIPHOSPHOLIPID SYNDROME. (2nd June 2020) Authors: Radin, M.; Cecchi, I.; Foddai, S. G.; Rubini, E.; Barinotti, A.; Sciascia, S.; Roccatello, D. Journal: Annals of the rheumatic diseases Issue: Volume 79(2020)Supplement 1 Page Start: 899 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. OP0048 TYPE I INTERFERON EXPRESSION IDENTIFIES DIFFERENT SUBSETS OF ANTIPHOSPHOLIPID SYNDROME. (2nd June 2020) Authors: Cecchi, I.; Radin, M.; Rubini, E.; Foddai, S. G.; Suárez, A.; Sciascia, S.; Roccatello, D.; Rodríguez-Carrio, J. Journal: Annals of the rheumatic diseases Issue: Volume 79(2020)Supplement 1 Page Start: 31 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗